abstract |
The invention is directed to inhibitors of mTOR and pharmaceutically acceptable salts or solvates thereof, as well as methods of using them. The inhibitors are generally of structural formula wherein the combination of R 1 and R 2 are as defined herein, and pharmaceutically acceptable salts thereof. |